Posts by Brian Westerlind
A First Look at AAHP Summit Speakers
We are thrilled to offer a first look at the speakers and sessions for our upcoming Summit on Challenges and Solutions in Quality & Safety of Homeopathic Drug Products! This…
Read MoreHow to Work with FDA on Voluntary Recalls
By Mary Borneman, Sr. Director, Communications & Public Affairs, Standard Homeopathic Company/Hyland’s, Inc. In April 2019, U.S. Food & Drug Administration (FDA) published a draft guidance* Initiation of Voluntary…
Read MoreSafe Drugs, Happy Consumers: Sterility Assurance Programs
By Kristina Skowronek, Director of Quality and Regulatory Compliance, Boiron USA USP GENERAL CHAPTERS, GENERAL INFORMATION, 〈1211〉 STERILIZATION AND STERILITY ASSURANCE OF COMPENDIAL ARTICLES If we were to manufacture a…
Read MoreInitiation of Voluntary Recalls: Draft Guidance for Industry and FDA Staff
By Mark Land, AAHP President Product recalls are an important tool that manufacturers and the U.S. Food and Drug Administration (FDA) use to minimize exposure to potentially harmful or…
Read MoreOverview: Membership Meeting 2019
The membership of AAHP came together on March 8 for the association’s semiannual Membership Meeting. Taking place during Natural Products Expo West in Anaheim, Calif., AAHP members convened to hear…
Read MoreReduce Risk with Product Substantiation
Susan J. Hewling When bringing products to market, it is essential to build a platform that allows all information generated to be available for future use,” advised Susan J.…
Read MoreThe Only Constant in Retail is Change
By Ray Petrick, Vice President of Sales, Boiron USA The retail landscape is changing—and dramatically. During the past 10 years, retail disruption has become the norm. The evolution of consumers…
Read MoreWhy Pharmacovigilance Matters
By Mark Land, AAHP President Pharmacovigilance is defined as the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problem.1 Serious…
Read MoreThe Homeopathic Pharmacopeia of India
By Eric L. Foxman A quick look at its structure and contents, as well as the potential for adulteration and misbranding in the U.S. market. Structure The Homeopathic Pharmacopeia of…
Read MoreAdvancing Global Collaborations: News from the World Integrated Medicine Forum
By Eric L. Foxman, Secretary AAHP We are very familiar with the regulatory status and acceptance of homeopathic medicines in the United States. We also have an impression of the…
Read More